BPMC
Price
$128.11
Change
-$0.04 (-0.03%)
Updated
Jun 27 closing price
Capitalization
8.27B
32 days until earnings call
TNFA
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
1.8M
Interact to see
Advertisement

BPMC vs TNFA

Header iconBPMC vs TNFA Comparison
Open Charts BPMC vs TNFABanner chart's image
Blueprint Medicines
Price$128.11
Change-$0.04 (-0.03%)
Volume$2.99M
Capitalization8.27B
TNF Pharmaceuticals
Price$0.13
Change-$0.00 (-0.00%)
Volume$5.36M
Capitalization1.8M
BPMC vs TNFA Comparison Chart in %
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. TNFA commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and TNFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BPMC: $128.11 vs. TNFA: $0.13)
Brand notoriety: BPMC and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 81% vs. TNFA: 96%
Market capitalization -- BPMC: $8.27B vs. TNFA: $1.8M
BPMC [@Biotechnology] is valued at $8.27B. TNFA’s [@Biotechnology] market capitalization is $1.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMC is a better buy in the long-term than TNFA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 2 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • BPMC’s TA Score: 2 bullish, 6 bearish.
  • TNFA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TNFA is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а -0.07% price change this week, while TNFA (@Biotechnology) price change was -8.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

TNFA is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.27B) has a higher market cap than TNFA($1.8M). BPMC YTD gains are higher at: 46.881 vs. TNFA (-88.957). TNFA has higher annual earnings (EBITDA): -8.35M vs. BPMC (-66.42M). BPMC has more cash in the bank: 576M vs. TNFA (5.88M). TNFA has less debt than BPMC: TNFA (2.68K) vs BPMC (467M). BPMC has higher revenues than TNFA: BPMC (562M) vs TNFA (0).
BPMCTNFABPMC / TNFA
Capitalization8.27B1.8M459,411%
EBITDA-66.42M-8.35M796%
Gain YTD46.881-88.957-53%
P/E RatioN/AN/A-
Revenue562M0-
Total Cash576M5.88M9,798%
Total Debt467M2.68K17,438,387%
FUNDAMENTALS RATINGS
BPMC vs TNFA: Fundamental Ratings
BPMC
TNFA
OUTLOOK RATING
1..100
7085
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
3797
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (8) in the null industry is significantly better than the same rating for BPMC (82) in the Biotechnology industry. This means that TNFA’s stock grew significantly faster than BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (54) in the Biotechnology industry is somewhat better than the same rating for TNFA (100) in the null industry. This means that BPMC’s stock grew somewhat faster than TNFA’s over the last 12 months.

BPMC's SMR Rating (96) in the Biotechnology industry is in the same range as TNFA (99) in the null industry. This means that BPMC’s stock grew similarly to TNFA’s over the last 12 months.

BPMC's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for TNFA (97) in the null industry. This means that BPMC’s stock grew somewhat faster than TNFA’s over the last 12 months.

BPMC's P/E Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for TNFA (100) in the null industry. This means that BPMC’s stock grew somewhat faster than TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCTNFA
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BADGER.X1.0022560.025890
+2.65%
Badger DAO cryptocurrency
SNX.X0.5781310.012993
+2.30%
Synthetix cryptocurrency
RLC.X0.8965860.009057
+1.02%
iExec RLC cryptocurrency
AUTO.X6.2752890.049525
+0.80%
Auto cryptocurrency
ICP.X4.7619580.031538
+0.67%
Internet Computer cryptocurrency

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-0.03%
KYMR - BPMC
49%
Loosely correlated
-3.48%
VERA - BPMC
47%
Loosely correlated
-2.71%
NRIX - BPMC
45%
Loosely correlated
+0.26%
APLS - BPMC
44%
Loosely correlated
-5.27%
IDYA - BPMC
42%
Loosely correlated
-4.04%
More